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The anesthetic medication to sedate a child during general anesthesia (GA) for oral cancer, adenoidectomy or 
tonsillectomy is associated with operative complications such as hemodynamic instability and long postoperative recovery 
period. The current advancement enables combination of different anesthetic medications to decrease operative or 
postoperative complications associated with GA. In this study assessed the effects of propofol combined with remifentanil 
on hemodynamics and stress response in children undergoing oral cancer, tonsil and adenoid surgery. Propofol combined 
with remifentanil is beneficial to anesthesia for children undergoing oral cancer tonsil and adenoid surgery, manifested as 
stable hemodynamics, rapid recovery, low inflammatory and stress responses, and mild adverse reactions. A total of 106 
eligible children treated from May 2017 to December 2019 were randomly divided into observation and control groups 
(n=53). Observation group was anesthetized by propofol plus remifentanil, while control group was anesthetized by 
propofol plus esketamine. Mean arterial pressure (MAP), heart rate (HR), serum C-reactive protein (CRP), interleukin-6 (IL-
6), tumor necrosis factor-α (TNF-α), epinephrine (E), cortisol (Cor), CD3+, CD4+ helper and CD8+ inhibitory T lymphocytes, 
and CD4+/CD8+were compared before anesthesia induction (T1), immediately after intubation (T2), at the beginning of 
operation (T3), at the end of operation (T4) and 5 min after extubation (T5). Time of anesthetic recovery and adverse 
reactions after extubation were observed. MAP and HR significantly rose at T2 compared with those at T1. After 
maintenance of anesthesia, MAP and HR were significantly lower in observation group than those in control group. Serum 
CRP, IL-6 and TNF-α levels rose with time. E and Cor levels rose from T1 to T4 and declined at T5, with significant 
differences at each time point. CRP, IL-6, TNF-α, E and Cor levels were lower in observation group from T3 to T5. At T4 
and T5, CD3+, CD4+levels and CD4+/CD8+ declined, whileCD8+level rose compared with those at other three time points. 
Time of recovery of autonomous respiration and limbs and duration from anesthetic withdrawal to extubation were 
significantly shorter in observation group. Observation group had lower incidence rate of dysphoria during recovery. 
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Chronic tonsillitis, adenoid hypertrophy and oral 
cancer both malignant and benign like SCC 
(squamous cell carcinoma) are the main causes of 
upper respiratory infection and snoring in children. In 
severe cases, they may affect the normal development 
of adjacent organs, leading to distraction, memory 
deterioration and even mental retardation in children
1
. 
At present, surgical resection is the main treatment 
method for oral cancer, tonsils and adenoids
2
. 
However, due to the abundant innervations in the 
mouth and throat, a strong stress response, 
hemodynamic fluctuations and even severe 
complications will still be caused despite short time of 
operation. In clinic, general anesthesia and tracheal 
intubation are often adopted for analgesia and 
sedation. Moreover, it is required to recover 
completely and quickly without dysphoria after 
operation. Hence, choosing appropriate anesthetic 
drug is extremely important
3,4
. 
In recent years, propofol and remifentanil is used 
clinically for anesthesia in pediatric oral cancer 
resection, tonsillectomy and adenoidectomy. 
However, the effects of such an anesthesia method on 
the hemodynamics and stress response in children are 
rarely reported. In the present study, therefore, 









combined with esketamine were compared in low 
temperature plasma ablation of oral cancer, tonsils 
and adenoids in children, aiming to explore the effects 
on hemodynamics and stress response, and provide a 
reliable clinical basis for the selection of anesthesia 
method. 
 
Material and Methods 
 
Subjects 
A total of 106 children scheduled to undergo low 
temperature plasma ablation of oral cancer, tonsils 
and adenoids in our hospital from May 2017 to 
December 2019 were selected and randomly divided 
into observation group (n=53) and control group 
(n=53). In observation group, there were 27 males and 
26 females aged 3-9 years, with an average of 
(5.83±1.42) years. The body weight was 14-28 kg, 
with an average of (21.67±6.29) kg, and the body 
height was 87-120 cm, with an average of 
(102.51±13.69) cm. In terms of the American Society 
of Anesthesiologists (ASA) grade, there were 30 
cases in grade I and 23 cases in grade II. In terms of 
the Mallampati class, there were 35 cases in class I 
and 18 cases in class II. In control group, there were 
29 males and 24 females aged 3-10 years, with an 
average of (5.87±1.50) years. The body weight was 
15-29 kg, with an average of (22.39±6.34) kg, and the 
body height was 88-122 cm, with an average of 
(104.07±13.82) cm. In terms of the ASA grade, there 
were 32 cases in grade I and 21 cases in grade II. In 
terms of the Mallampati class, there were 34 cases in 
class I and 19 cases in class II. Inclusion criteria: (i) 
Children with resectable grade of oral cancer as per 
TNM staging; (ii) Children aged above 2 years, (iii) 
those who often suffered from recurrent colds, nasal 
congestion and discharge, accompanied by varying 
degrees of snoring and mouth breathing; (iv) those 
with tonsillar hypertrophy ≥degree II complicated 
with adenoid hypertrophy shown in clinical 
examination, and meeting the indications for surgical 
resection of tonsils and adenoids; (v) those in ASA 
grade I or II and Mallampati class I or II; and (vi) 
those whose families were informed and signed the 
informed consent. Exclusion criteria: (i) children with 
arrhythmia, congenital heart disease or other organ 
dysfunctions; (ii) those with obesity (20% above the 
standard body weight); (iii) those with mental 
retardation, neurological disorder or severe 
developmental disorder, (iv) those with airway 
anomaly or recent upper respiratory infection; (v) 
those allergic to anesthetic drugs or other drugs used 
during operation; (vi) those with severe 
laryngospasm, massive bleeding or other adverse 
events during the perioperative period, or 7) those 
who failed to strictly carry out the trial protocol due to 
various reasons. This study was approved by the 
Medical Ethics Committee of our hospital. The 
gender, age, body weight, body height, ASA grade 
and Mallampati class had no statistically significant 
differences between the two groups (P >0.05), and 
they were comparable (Table 1). 
 
Anesthesia methods 
The patients were deprived of food and water for  
6 h and 2 h, respectively, before operation. After 
entering the operating room, the patients were 
routinely subjected to mask oxygen inhalation and 
connected to a monitor, and a disposable EEG  
sensor was placed to monitor the values. Atropine 
(0.01 mg·kg
-1
), 5 mg of dexamethasone, midazolam 
(0.1 mg·kg
-1
), propofol (3.0 mg·kg
-1
), fentanyl (2 
μg·kg
-1
) and cis-atracurium (0.1 mg·kg
-1
) were 







Gender (n, %)   0.151 0.697 
Male  27 (50.94) 29 (54.72)   
Female  26 (49.06) 24 (45.28)   
Age (years,χ±s) 5.83±1.42 5.87±1.50 0.141 0.888 
Body wt. (kg, χ±s) 21.67±6.29 22.39±6.34 0.587 0.559 
Body ht. (cm, χ±s) 102.51±13.69 104.07±13.82 0.584 0.561 
ASA grade (n, %)   0.155 0.693 
Grade I 30 (56.60) 32 (60.38)   
Grade II 23 (43.40) 21 (39.62)   
Mallampati class (n, %)  0.042 0.839 
Class I 35 (66.04) 34 (64.15)   
Class II 18 (33.96) 19 (35.85)   
Hemodynamic indices 
MAP (mmHg, χ±s)    
T1 74.59±6.75 73.98±6.69 0.467 0.641 
T2 77.45±7.36a 79.43±7.51a 1.371 0.173 
T3 74.78±6.92* 78.34±7.25a 2.586 0.011 
T4 72.43±6.58b* 75.26±6.79bc 2.179 0.032 
T5 81.52±7.84abcd* 85.47±8.16abcd 2.541 0.013 
HR (beats/min, χ±s)    
T1 100.63±10.39 104.96±12.25 1.962 0.052 
T2 120.81±13.74a 122.53±13.91a 0.640 0.523 
T3 99.61±10.68b* 113.72±12.50ab 6.248 0.000 
T4 96.74±9.95b* 100.65±9.89abc 2.029 0.045 
T5 100.52±10.15b* 108.24±12.46bcd 3.497 0.001 
[aP <0.05 vs. T1, bP <0.05 vs. T2, cP <0.05 vs. T3, dP <0.05 vs. 
T4, and *P <0.05 vs. control group] 
 




intravenously injected for anesthesia induction.  
After muscular relaxation, tracheal intubation was 
performed under the assistance of a visual 















) was continuously pumped, and 0.1% 
esketamine solution was intravenously infused for 
maintenance of anesthesia. During operation, the 
dosage of propofol was adjusted according to entropy 
index which was kept at 45-55. The pumping volume 
of propofol was reduced if entropy index was lower 
than 45, while propofol (0.5 mg·kg
-1
) was added if 
entropy index was higher than 55. The drugs were 
withdrawn at 5 min before the end of operation. After 
the recovery of consciousness, cough reflex and tidal 
volume in children, the oropharyngeal secretions and 
blood were sucked clean, and the tracheal catheter 
was removed. Finally, the children could be sent back 
to the ward if no adverse reactions such as nausea, 
vomiting, bucking and dysphoria were found. 
 
Observation indices 
The hemodynamic indices mean arterial pressure 
(MAP) and heart rate (HR) were recorded before 
anesthesia induction (T1), immediately after 
intubation (T2), at the beginning of operation (T3), at 
the end of operation (T4), and at 5 min after 
extubation (T5). At T1, T2, T3, T4 and T5, fasting 
venous blood was drawn and centrifuged after 
coagulation, and the serum was collected for later use. 
Then the serum C-reactive protein (CRP), interleukin-
6 (IL-6), tumor necrosis factor-α (TNF-α) and 
epinephrine (E) were detected via enzyme-linked 
immunosorbent assay, and cortisol (Cor) was detected 
via radioimmunoassay. The cluster of differentiation 
(CD)
3+
 T lymphocytes, CD
4+ 
helper T lymphocytes, 
CD
8+





were determined using a FACSCalibur flow 
cytometer (BD, USA). The anesthetic recovery was 
observed, and the time of recovery of autonomous 
respiration and limbs and the duration from anesthetic 
withdrawal to extubation were recorded. The adverse 
reactions after extubation were observed. 
 
Statistical analysis 
SPSS 19.0 was used for statistical analysis. 
Quantitative data were expressed as mean±standard 
deviation (χ±s). Repeated measures analysis of 
variance was performed for intergroup comparison at 
multiple time points. In the case of statistical 
significance, q test was employed for intergroup 
comparison at the same time point, while paired t test 
was used for intragroup comparison at two different 
time points. Numerical data were expressed as case 
(%), andχ
2
 test was performed. P<0.05 was 





In observation group, MAP was significantly 
higher at T2 than that at T1 (P <0.05), then stayed  
at a low level until the end of operation, and  
rose again at T5 and was significantly higher than  
that at any previous time point (P <0.05). In control 
group, MAP was significantly higher at T2 than  
that at T1 (P <0.05), then stayed at a higher level than 
that at T1 until the end of operation, and also 
significantly rose again at T5 (P <0.05). MAP had no 
statistically significant difference between the two 
groups at T1 and T2 (P >0.05), while it was lower  
in observation group than that in control group from 
T3 to T5, showing statistically significant differences 
(P <0.05). 
In observation group, HR was significantly 
increased at T2 compared with that at T1 (P <0.05), 
declined at T3 and had no significant difference from 
T3 to T5 compared with that at T1 (P >0.05). In 
control group, HR was significantly increased at T2 
compared with that at T1 (P <0.05), significantly 
declined from T3 to T4 (P <0.05), and increased at T5 
and had no significant difference from that at T1  
(P >0.05). HR had no statistically significant difference 
between the two groups at T1 and T2 (P >0.05), while 
it was lower in observation group than that in control 
group from T3 to T5, showing statistically significant 
differences (P <0.05) (Table 1). 
 
Inflammatory response indices 
The levels of serum CRP, IL-6 and TNF-α in the 
two groups rose with time, and there were statistically 
significant differences (P <0.05). Their levels had no 
statistically significant differences between the two 
groups at T1 and T2 (P >0.05), while they were lower 
in observation group than those in control group from 
T3 to T5, displaying statistically significant 
differences (P <0.05) (Table 2). 
 
Stress response indices 
The levels of serum E and Cor in the two groups 
gradually rose from T1 to T4 and declined at T5, and 
there were statistically significant differences at each 
time point (P <0.05). The levels of serum E and Cor 
had no statistically significant differences between the 




two groups at T1 and T2 (P >0.05), while they were 
lower in observation group than those in control 
group from T3 to T5, with statistically significant 
differences (P <0.05) (Table 3). 
 
Immune function indices 









 declined, while the level of CD
8+
 rose in 
the two groups, showing statistically significant 
differences compared with those at the other three 
time points (P <0.05), but there were no statistically 
significant differences between the two groups at each 
time point (P >0.05) (Table 3). 
 
Anesthetic recovery times 
The time of recovery of autonomous respiration 
and limbs and the duration from anesthetic 
withdrawal to extubation were significantly shorter in 
observation group than those in control group, and the 




Observation group had a lower incidence rate of 
dysphoria during the recovery period than control 
group, and the difference was statistically significant 
(P <0.05). The incidence rates of upper respiratory 
tract obstruction or apnea, nausea and vomiting had 
no statistically significant difference between the two 
groups (P>0.05) (Table 4). 
Table 2 — Inflammatory response indices 





CRP (mg/L, χ±s)    
T1 56.77±6.82 57.03±6.86 0.196 0.845 
T2 67.21±7.76 a 67.64±7.79 a 0.285 0.776 
T3 93.58±10.49 ab* 114.28±12.53 ab 9.222 0.000 
T4 116.39±12.87abc* 129.57±13.21abc 5.203 0.000 
T5 134.16±14.08abcd* 145.71±15.12abcd 4.070 0.000 
IL-6 (ng/L, χ±s)    
T1 26.04±3.25 25.89±3.17 0.241 0.810 
T2 32.15±3.79 a 31.26±3.68 a 1.227 0.223 
T3 40.27±4.18 ab* 54.32±5.74 ab 14.405 0.000 
T4 52.38±5.66abc* 62.45±6.39abc 8.588 0.000 
T5 66.52±6.79abcd* 73.64±7.46abcd 5.139 0.000 
TNF-α (ng/L, χ±s)    
T1 45.82±5.36 46.03±5.41 0.201 0.841 
T2 49.76±5.84 a 50.11±5.92 a 0.306 0.760 
T3 56.29±6.45 ab* 62.94±6.83 ab 5.153 0.000 
T4 61.34±6.93abc* 67.76±7.15abc 4.694 0.000 
T5 69.58±7.37abcd* 75.29±7.68abcd 3.905 0.000 
[aP <0.05 vs. T1, bP <0.05 vs. T2, cP <0.05 vs. T3, dP <0.05 vs. 
T4, and *P <0.05 vs. control group] 
 






Stress response indices 
E (ng/mL, χ ± s)    
T1 38.96±4.57 40.15±4.73 1.317 0.191 
T2 49.78±6.39 a 51.07±6.48 a 1.032 0.304 
T3 61.63±7.82 ab* 77.46±8.69 ab 9.858 0.000 
T4 78.15±8.46abc* 85.21±9.64abc 4.007 0.000 
T5 53.37±5.61abcd* 68.39±7.57abcd 11.605 0.000 
Cor (pg/mL, χ ± s)    
T1 149.52±15.69 151.37±15.86 0.604 0.547 
T2 167.38±17.24 a 168.92±17.53 a 0.456 0.649 
T3 182.71±19.45 ab* 236.85±24.29 ab 12.666 0.000 
T4 203.46±20.76abc* 272.55±28.41abc 14.295 0.000 
T5 191.69±19.57abcd* 219.43±22.78abcd 6.725 0.000 
Immune function indices 
CD3+ (%, χ±s)    
T1 51.92±5.83 52.13±5.87 0.185 0.854 
T2 50.85±5.76 51.68±5.79 0.740 0.461 
T3 51.36±5.81 51.79±5.84 0.380 0.705 
T4 43.07±4.42abc 42.95±4.36abc 0.141 0.888 
T5 42.59±4.38abc 42.37±4.32abc 0.260 0.795 
CD4+ (%, χ±s)    
T1 31.78±3.35 32.13±3.42 0.532 0.596 
T2 31.54±3.31 31.86±3.37 0.493 0.623 
T3 30.92±3.28 30.89±3.25 0.047 0.962 
T4 22.16±2.34abc 21.92±2.29abc 0.534 0.595 
T5 21.83±2.27abc 21.75±2.24abc 0.183 0.855 
CD8+ (%, χ±s)    
T1 20.86±2.13 21.05±2.16 0.456 0.649 
T2 21.10±2.19 21.32±2.24 0.511 0.610 
T3 21.03±2.17 21.28±2.29 0.577 0.565 
T4 29.79±3.05abc 30.11±3.10abc 0.536 0.593 
T5 30.25±3.08abc 30.15±3.12abc 0.166 0.868 
CD4+/CD8+     
T1 1.53±0.46 1.54±0.47 0.111 0.912 
T2 1.49±0.43 1.50±0.44 0.118 0.906 
T3 1.48±0.41 1.47±0.40 0.127 0.899 
T4 0.74±0.20abc 0.72±0.21abc 0.502 0.616 
T5 0.72±0.19abc 0.71±0.18abc 0.278 0.781 
[aP <0.05 vs. T1, bP <0.05 vs. T2, cP <0.05 vs. T3, dP <0.05 vs. 
T4, and *P <0.05 vs. control group] 
 






Time of recovery of 
autonomous respiration 
(min, χ±s) 
4.12±1.87 6.93±2.51 6.536 0.000 
Time of recovery of limbs 
(min, χ±s) 
5.03±1.26 8.34±1.42 12.693 0.000 
Duration from anesthetic 
withdrawal to extubation 
(min, χ±s) 
6.25±1.48 10.72±2.57 10.973 0.000 
Adverse reaction     
Dysphoria during the 
recovery period (n, %) 
5(9.43) 19(35.85) 10.557 0.001 
Upper respiratory tract 
obstruction or apnea (n, %) 
3(5.66) 9(16.98) 3.383 0.066 
Nausea and vomiting (n, %) 7(13.21) 8(15.09) 0.078 0.780 





Narrow oropharyngeal cavity and fragile mucous 
membrane in children causes swelling of uvula  
and surgical cavity and elevation in respiratory 
resistance in the pharyngeal cavity after low 
temperature plasma ablation of oral cancer, tonsils 
and adenoids, leading to a high risk of serious adverse 
reactions. At present, general anesthesia is adopted in 
short duration operations, in which it is required to 
maintain a certain depth of anesthesia during 
operation, and ensure rapid recovery after operation, 
without causing delayed respiratory depression and 
metabolic residues of anesthetic drugs. However, the 
organ functions of children have not been fully 
developed, which may affect the metabolism of 
intravenous anesthetics and lead to residues in the 
body. Hence, it is important to select appropriate 
anesthetic drugs. In recent years, propofol has been 
widely used in clinic. As an alkylphenol intravenous 
anesthetic, propofol is characterized by fast onset of 
action, short effectiveness, quick recovery and easily-
controlled depth of anesthesia. However, the 
analgesic effect is poor and the body motion response 
will be caused when used alone, while increased 
dosage will lead to suppression of circulatory and 
respiratory system. Therefore, propofol is often 




Esketamine is a traditional intravenous anesthetic 
used in combination with propofol for pediatric 
surgical anesthesia previously, which is still widely 
applied in primary hospitals. It is characterized by fast 
onset of action, small impact on the respiratory 
system, and a good surface analgesic effect, but 
repeated use will lead to tolerance and cause many 
adverse reactions
6
. With the development of 
anesthesiology, remifentanil (a new generation of 
opioid receptor agonist) is often used in combination 
with propofol
7
. Remifentanil can reach blood-brain 
balance in about 1 min in the human body, and be 
rapidly degraded by non-specific esterase in the blood 
and tissues. Therefore, with fast onset of action, short 
effectiveness, complete elimination and rapid 
recovery, is suitable for short-duration operations, 
which causes little damage to liver and kidney 





Although the combined use of anesthesia-inducing 
drugs was reasonable in this study, intubation 
reactions still occurred in a small number of children, 
leading to a certain increase in MAP and HR. It is 
reported in the literature that remifentanil can result in 
bradycardia and hypotension in a dose-dependent 
manner, while the adverse reaction of esketamine is 
elevation of blood pressure
9,10





) combined with 
propofol was applied for maintenance of anesthesia, 
and no severe bradycardia and hypotension occurred. 
Although the changes in MAP and HR were not 
completely consistent at each time point, the 
monitored values of MAP and HR in observation 
group were obviously lower than those in control 
group after maintenance of anesthesia, consistent with 
the above literature
9
. Moreover, MAP and HR 
remained more stable till the end of operation in 
observation group, consistent with the research results 
of Unsal et al.
11
. A possible explanation is that the 
side effects of remifentanil are in a dose-dependent 
manner, and the combination of remifentanil and 
propofol reduces side effects through lowering their 
respective dosage. In addition, intravenous pumping 
can better maintain the stability of plasma drug 
concentration and effectively control noxious stimuli, 
thereby stabilize hemodynamics. 
 
It has long been confirmed in a large number of 
studies that a series of inflammatory and stress 
responses can be induced by anesthesia and surgical 
stimulation against the body, and the immune system 
can also be inhibited. However, the degrees of 
reactions caused by different anesthetic drugs and 
methods are quite different
12
. Herein, the results 
showed that propofol combined with remifentanil 
could effectively relieve the inflammatory response; 
consistent with the study of Yuan that remifentanil 
combined with propofol can reduce the production  
of inflammatory factors in senile orthopedic  
surgery
13
. After being transmitted to the nerve  
center, noxious stimulus signals can stimulate two 
systems, hypothalamus-pituitary-adrenal cortex and 
sympathetic-adrenal medulla, leading to the synthesis 
of adrenal cortex and adrenal medulla, so that the 
secretion of Cor and E is enhanced. Therefore, serum 
E and Cor can be used to indicate the body’s stress 
response level
14
. In this study, propofol combined 
with remifentanil had an inhibitory effect on the stress 
response, being consistent with a previous literature
15
. 
The reason is that remifentanil may affect the release 
of inflammatory factors through interference with the 
synthesis of prostaglandin. Moreover, it can activate 
opioid receptors of the central and peripheral nerves, 




and reduce the release of C-fiber noxious 
neurotransmitters, thereby inhibiting the nociceptor 
sensitization induced by inflammatory mediators, and 
ultimately easing pain and alleviating inflammatory 
and stress responses. However, the anesthetic drugs 
and methods used in this study had little impact on the 
immune function of children, which was in 
accordance with the findings of Zhang et al.
16
.  
The time of anesthetic recovery in observation  
group was significantly shorter than that in  
control group. One reason is that remifentanil has 
unique pharmacokinetic characteristics, that is, its 
metabolism does not rely on liver and kidney 
functions and is not affected by individual 
differences, similar to the drug clearance rate in 
adults. The other reason is that the metabolite of 
esketamine still possesses 1/5-1/3 of its anesthetic 
potency and has a longer elimination half-life, which 
often leads to re-drowsiness after awakening
17
. 
Furthermore, observation group had an obviously 
lower incidence rate of dysphoria during the recovery 
period than control group.The above finding was 
consistent with related reports that esketamine can 
lead to such mental symptoms as hallucinations, 






The combination of propofol and remifentanil with 
unique pharmacokinetic and pharmacodynamic 
characteristics has more advantages in anesthesia  
for children undergoing low-temperature plasma 
ablation of oral cancer, tonsils and adenoids. It had 
more stable hemodynamics, lower levels of 
inflammatory and stress responses, and showed rapid 
recovery with fewer adverse reactions. Observatinos 
of this study support its clinical popularization  
and application in pediatric operations that require 
general anesthesia. 
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